ClinicalTrials.Veeva

Menu

Fear-focused Self-Compassion Therapy for Young Breast Cancer Patients' Fear of Cancer Recurrence

S

Shaanxi Normal University

Status

Enrolling

Conditions

Fear of Cancer Recurrence

Treatments

Behavioral: Fear-focused Self-Compassion Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04965428
Self-compassion FCR

Details and patient eligibility

About

Few studies have tailored psychological intervention for fear of cancer recurrence (FCR) in young breast cancer patients, and the long-term efficacy of psychological intervention and its underlying mechanism are still unknown. To fill this knowledge gap, this protocol aims to evaluate the short-term and long-term effectiveness of Fear-focused Self-Compassion Therapy, as well as this therapy's psychological and physiological mechanisms in reducing severe FCR in young women with breast cancer.

This study will be a randomized controlled trial recruiting 160 Chinese young female breast cancer patients with severe FCR. Participants will be randomized to the Fear-focused Self-Compassion Therapy group or control group (1:1). Measurement will be completed at baseline (T0), immediately completing intervention (T1), after 3 months (T2), after 6 months (T3) and after 12 months (T4). Primary outcomes are FCR severity; secondary outcomes are self-compassion, neurophysiological data (i.e., salivary alpha amylase and heart rate variability), attentional bias for FCR, rumination, catastrophizing thinking, and psychological symptoms. The Fear-focused Self-Compassion Therapy is based on the theories of FCR development and self-compassion, and consists of eight-week face to face group sessions.

Enrollment

160 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (1) are diagnosed with breast cancer (including various cancer stages and subtypes);
  • (2) are aged 18-45 years;
  • (3) can sign written informed consent;
  • (4) can read and write Chinese;
  • (5) have severe FCR, with scores > 13 on the FCRI severity subscale.

Exclusion criteria

  • (1) currently have psychiatric and psychological illness;
  • (2) have other types of tumor;
  • (3) had a previous cancer recurrence;
  • (4) are participating another psychological intervention at the start of the study or during their eight-week therapy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

160 participants in 2 patient groups

Fear-focused Self-Compassion Therapy
Experimental group
Description:
Experimental group receives group face-to-face Fear-focused Self-Compassion Therapy for eight weeks.
Treatment:
Behavioral: Fear-focused Self-Compassion Therapy
Usual care
No Intervention group
Description:
The no intervention group receives usual care supported by hospital or coming from elsewhere for eight weeks.

Trial contacts and locations

1

Loading...

Central trial contact

Lei Zhu, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems